2310034C09Rik Activators
2310034C09Rik Activators comprise a diverse group of chemical compounds that indirectly enhance the functional activity of 2310034C09Rik through various biochemical mechanisms. For instance, Forskolin and IBMX elevate intracellular levels of cAMP and cGMP, respectively, leading to the activation of PKA and the accumulation of secondary messengers that can phosphorylate substrates influencing 2310034C09Rik's activity. Similarly, PMA, as a PKC activator, and A23187, through its role as a calcium ionophore, both contribute to the activation of signaling pathways potentially involved in the enhancement of 2310034C09Rik. Moreover, Sphingosine-1-phosphate, as a lipid signaling molecule, and Genistein, as a tyrosine kinase inhibitor, can modulate the cellular signaling landscape in a way that favors 2310034C09Rik's pathway activation and thus its functional enhancement.
A cadre of chemical compounds known to enhance the functional activity of 2310034C09Rik operates through intricate cellular signaling mechanisms. Forskolin and IBMX, for example, act by elevating the levels of cAMP and cGMP, respectively, thus activating protein kinase A (PKA). PKA consequently phosphorylates specific substrates within the signaling network of 2310034C09Rik, which enhances its activity. Similarly, PMA, through activation of protein kinase C (PKC), and A23187, by elevating intracellular calcium, trigger downstream signaling pathways that lead to the phosphorylation and activation of proteins associated with 2310034C09Rik. Additionally, Sphingosine-1-phosphate, a lipid signaling molecule, and Genistein, a tyrosine kinase inhibitor, orchestrate a favorable signaling milieu for the activation of 2310034C09Rik by modulating phosphorylation cascades.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. This can indirectly enhance 2310034C09Rik by sustaining the signaling pathways that are cAMP-dependent. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate various signaling cascades. These cascades can phosphorylate proteins and possibly enhance the activity of 2310034C09Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, activating calcium-dependent protein kinases and signaling pathways that can upregulate 2310034C09Rik activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which initiate signaling cascades that could upregulate 2310034C09Rik activity through phosphorylation events. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which may reduce competitive signaling pathways, possibly allowing for the enhanced activity of 2310034C09Rik through its own signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which can alter the PI3K/AKT pathway, potentially allowing for alternative pathways to activate and enhance 2310034C09Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may alter signaling dynamics, potentially resulting in the upregulation of alternative pathways that enhance the activity of 2310034C09Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium storage and can increase cytosolic calcium levels, which may enhance 2310034C09Rik activity through calcium-dependent signaling mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, which might reduce inhibitory phosphorylation events, potentially enhancing signaling pathways that activate 2310034C09Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can modify downstream signaling, possibly enhancing the activity of 2310034C09Rik through alternative signaling routes. | ||||||